Ubs Asset Management Americas Inc Kura Oncology, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 189,720 shares of KURA stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
189,720
Previous 152,132
24.71%
Holding current value
$1.82 Million
Previous $1 Million
8.96%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding KURA
# of Institutions
189Shares Held
79.5MCall Options Held
53.6KPut Options Held
42.8K-
Suvretta Capital Management, LLC New York, NY8.12MShares$77.7 Million1.61% of portfolio
-
Bvf Inc San Francisco, CA7.75MShares$74.2 Million1.76% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$66.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.2MShares$59.3 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$51.2 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $640M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...